News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Bristol-Myers Squibb Canada Profit Triples on Sale of Device Unit
October 23, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK (Reuters) - Bristol-Myers Squibb Co on Thursday said third-quarter earnings tripled from the sale of its ConvaTec wound-healing unit and higher drug sales, but the company took another big charge for soured investments.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoff Tracker
10x Genomics Slashes 8% of Headcount in Savings Push
May 13, 2025
·
200 min read
·
BioSpace Editorial Staff
Funding
Azafaros Raises $150M To Target Rare Neuro-Metabolic Diseases
May 13, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Lexeo Trims 15% of Workforce, Shifts Focus to Lead Cardiac Programs
May 12, 2025
·
1 min read
·
Angela Gabriel
Manufacturing
Roche makes $300M China Production Promise After Multibillion US Investment
May 12, 2025
·
2 min read
·
Tristan Manalac
